SG Americas Securities’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-76,200
| Closed | -$297K | – | 3259 |
|
|
2022
Q3 | $297K | Buy |
+76,200
| New | +$6.8M | ﹤0.01% | 2000 |
|
|
2022
Q2 | – | Sell |
-36,100
| Closed | -$6K | – | 3529 |
|
|
2022
Q1 | $6K | Sell |
36,100
-228,700
| -86% | -$18M | ﹤0.01% | 2906 |
|
|
2021
Q4 | $143K | Sell |
264,800
-675,800
| -72% | -$53.8M | ﹤0.01% | 2857 |
|
|
2021
Q3 | $4.44M | Buy |
940,600
+654,500
| +229% | +$49.8M | 0.02% | 620 |
|
|
2021
Q2 | $903K | Buy |
286,100
+128,900
| +82% | +$9.59M | ﹤0.01% | 1621 |
|
|
2021
Q1 | $351K | Sell |
157,200
-356,320
| -69% | -$26.3M | ﹤0.01% | 2255 |
|
|
2020
Q4 | $215K | Sell |
513,520
-47,160
| -8% | -$3.61M | ﹤0.01% | 2586 |
|
|
2020
Q3 | $713K | Sell |
560,680
-1,266,403
| -69% | -$99.2M | ﹤0.01% | 1407 |
|
|
2020
Q2 | $7.05M | Buy |
1,827,083
+1,453,681
| +389% | +$109M | 0.06% | 248 |
|
|
2020
Q1 | $2.32M | Sell |
373,402
-300,148
| -45% | -$23.6M | 0.02% | 716 |
|
|
2019
Q4 | $298K | Buy |
673,550
+111,403
| +20% | +$9.15M | ﹤0.01% | 2199 |
|
|
2019
Q3 | $416K | Sell |
562,147
-165,375
| -23% | -$13.3M | ﹤0.01% | 1996 |
|
|
2019
Q2 | $880K | Sell |
727,522
-491,302
| -40% | -$37.6M | 0.01% | 1513 |
|
|
2019
Q1 | $1.05M | Sell |
1,218,824
-65,814
| -5% | -$4.92M | 0.01% | 1252 |
|
|
2018
Q4 | $895K | Buy |
1,284,638
+265,144
| +26% | +$18.7M | 0.01% | 1422 |
|
|
2018
Q3 | $579K | Buy |
1,019,494
+337,665
| +50% | +$21.5M | ﹤0.01% | 2046 |
|
|
2018
Q2 | $1.13M | Sell |
681,829
-380,214
| -36% | -$21.5M | 0.01% | 1331 |
|
|
2018
Q1 | $3.56M | Sell |
1,062,043
-156,047
| -13% | -$8.43M | 0.03% | 571 |
|
|
2017
Q4 | $2.75M | Buy |
1,218,090
+117,795
| +11% | +$6.53M | 0.03% | 684 |
|
|
2017
Q3 | $1.01M | Buy |
1,100,295
+409,244
| +59% | +$24.8M | 0.01% | 1255 |
|
|
2017
Q2 | $809K | Buy |
691,051
+411,445
| +147% | +$25M | 0.01% | 1553 |
|
|
2017
Q1 | $325K | Sell |
279,606
-1,798,578
| -87% | -$109M | ﹤0.01% | 2127 |
|
|
2016
Q4 | $1.47M | Hold |
2,078,184
| – | – | 0.01% | 1085 |
|
|
2016
Q3 | $1.44M | Hold |
2,078,184
| – | – | 0.02% | 928 |
|
|
2016
Q2 | $3.06M | Buy |
2,078,184
+368,896
| +22% | +$19.6M | 0.02% | 593 |
|
|
2016
Q1 | $3.64M | Buy |
1,709,288
+189,583
| +12% | +$9.29M | 0.03% | 524 |
|
|
2015
Q4 | $3.05M | Buy |
+1,519,705
| New | +$76.6M | 0.02% | 532 |
|
|
2015
Q3 | – | Sell |
-1,324,882
| Closed | -$3.16M | – | 2481 |
|
|
2015
Q2 | $3.16M | Buy |
1,324,882
+709,811
| +115% | +$39.8M | 0.02% | 532 |
|
|
2015
Q1 | $871K | Sell |
615,071
-1,093,274
| -64% | -$61.9M | 0.01% | 1206 |
|
|
2014
Q4 | $9.92M | Buy |
1,708,345
+27,248
| +2% | +$1.52M | 0.05% | 393 |
|
|
2014
Q3 | $8.06M | Buy |
1,681,097
+1,346,785
| +403% | +$75.6M | 0.05% | 369 |
|
|
2014
Q2 | $687K | Buy |
334,312
+269,860
| +419% | +$14.7M | ﹤0.01% | 1545 |
|
|
2014
Q1 | $103K | Sell |
64,452
-952,003
| -94% | -$49.3M | ﹤0.01% | 2208 |
|
|
2013
Q4 | $356K | Sell |
1,016,455
-54,182
| -5% | -$2.48M | ﹤0.01% | 1736 |
|
|
2013
Q3 | $455K | Sell |
1,070,637
-136,449
| -11% | -$6.23M | ﹤0.01% | 1670 |
|
|
2013
Q2 | $1.28M | Buy |
+1,207,086
| New | +$53.9M | 0.01% | 915 |
|
Other funds holding MRK
VCM
VPM
SG Americas Securities's MRK Position: Q1 2026 in Review
SG Americas Securities increased its Merck (MRK) stake by 20% in Q1 2026, buying an estimated $31.6M and bringing the position to 1,665,520 shares worth $200M. The position accounts for 0.22% of the portfolio, ranked #75.
SG Americas Securities first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- SG Americas Securities held 1,665,520 shares of Merck worth $200M as of Q1 2026.
- SG Americas Securities bought 274,129 Merck shares in Q1 2026, an estimated $31.6M.
- Merck made up 0.22% of SG Americas Securities's portfolio in Q1 2026, its #75 holding.
- SG Americas Securities first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.